Atopic

Wilmington, Delaware, United States, July 31, 2023 (GLOBE NEWSWIRE) -- The global atopic dermatitis drugs market stood at US$ 6.0 billion in 2021, and the global market is projected to reach US$ 29.4 billion by 2031. The global industry…

SAN MATEO, Calif. and SINGAPORE, July 05, 2023 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (“ASLAN”, Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of…

SAN MATEO, Calif. and SINGAPORE, June 23, 2023 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (“ASLAN”, Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of…

Lori Solomon WEDNESDAY, May 31, 2023 (HealthDay News) -- Atopic dermatitis (AD) in adulthood is associated with an increased risk for venous thromboembolism (VTE), according to a study…

Ongoing phase 1b trial is designed to evaluate safety, tolerability, and efficacy of si-544 in T-cell mediated autoimmunity Dosing of MAD stage has been initiated; first results expected for late summer 2023 San Diego, CA, USA, and…

<!-- Name:DistributionId Value:8832285 --> <!-- Name:EnableQuoteCarouselOnPnr Value:True --> <!-- Name:IcbCode Value: -->…

<!-- Name:DistributionId Value:8824587 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:2790 -->…

Elana Gotkine TUESDAY, March 28, 2023 (HealthDay News) -- Patients with atopic disease have an increased risk of developing osteoarthritis (OA), according to a study published online March 27 in the…

Elana Gotkine MONDAY, March 27, 2023 (HealthDay News) -- Adults with atopic dermatitis (AD) have an increased risk for developing melanoma, basal cell carcinoma (BCC), and squamous cell carcinoma (SCC),…

<!-- Name:DistributionId Value:8791865 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4577 -->…